Ascendis Pharma A/S (ASND) insider trading
Every open-market stock purchase and sale by Ascendis Pharma A/S executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- Insiders bought $192K over the last 12 months (4 buys).
- Insiders sold $4.6M over the last 12 months (1 sale).
- Last insider buy: Scott Thomas Smith (CFO), $21.9K, 4 months ago.
Last 12 months: insiders bought $192K (4 buys) and sold $4.6M (1 sale).
Recent ASND insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Jun 2, 2026 | Scott Thomas Smith (CFO) | Bought | $21.9K |
| May 29, 2026 | Scott Thomas Smith (CFO) | Bought | $55.8K |
| May 29, 2026 | Jean Jacques Bienaime (Insider) | Bought | $44.5K |
| May 29, 2026 | Jean Jacques Bienaime (Insider) | Bought | $22.4K |
| May 26, 2026 | Jean Jacques Bienaime (Insider) | Bought | $47.9K |
| May 11, 2026 | Flemming Steen Jensen (Insider) | Sold | $4.6M |
Who's trading ASND
- Scott Thomas Smith, CFO: bought $77.7K (2 buys), last Jun 2, 2026
- Jean Jacques Bienaime, Insider: bought $115K (3 buys), last May 29, 2026
- Flemming Steen Jensen, Insider: sold $4.6M (1 sale), last May 11, 2026
Get free alerts when an insider at Ascendis Pharma A/S files a new trade →